Dr. Khadijah is a Consultant Public Health Pharmacist with over twenty years’ experience working with the National Agency for Food and Drug Administration and Control (NAFDAC) across the Enforcement, Registration, and Establishment Inspection functions of the Agency.

She holds a B. Pharm., Master of Public Health, M.Sc. Regulatory Science and a Fellowship of the West African Postgraduate College of Pharmacists.

Dr. Khadijah Ade-Abolade is the Director in charge of the Vaccines, Biologics, and Medical Devices Registration and Regulatory Affairs Directorate of NAFDAC. She leads multidisciplinary teams in the Directorate that carry out all the reviews of technical documentation and other activities leading to the issuance of market authorization of vaccines, biologics, and medical devices, including emergency use authorizations and post-approval changes to registered products. She is also responsible for authorizing donations of vaccines and medical devices for humanitarian and public health needs.

She is a Lead Pharmaceutical Good Manufacturing Practice (GMP) Inspector and Quality Management Systems (QMS) expert, and she has led numerous GMP Inspection Teams to assess GMP compliance of domestic and foreign facilities, informing regulatory decisions on the facilities and the manufactured products.

She is a key participant in the technical working groups responsible for the development of the NAFDAC Medical Devices and GMP for Pharmaceutical Products Regulations and Guidelines, as well as ongoing review of these regulatory tools for continued adequacy. She is also a member of the NAFDAC QMS Steering Committee, which is responsible for monitoring and maintenance of the QMS of the Agency. She is also a member of the NAFDAC Strategic Planning and NAFDAC Greenbook Committees.

Dr. Khadijah Ade-Abolade is the focal person for NAFDAC in the ongoing efforts in preparation for effective regulation of locally manufactured vaccines in Nigeria. She is a member of the National Technical Working Group for Local Vaccine Manufacturing and the Lead of the Regulatory Sub-Team in the Group. She has represented the Agency at several local and international meetings and trainings geared towards preparedness for sustainable local vaccine manufacturing in Nigeria and the African continent. She represents NAFDAC in the Operations Team of the African Maturity Level 3 NRAs Reliance Mechanism as well as on the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) Q1/Q5C Expert Working Group.